We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.23B
AUM Growth
-$1.54B
Cap. Flow
-$88.6M
Cap. Flow %
-1.08%
Top 10 Hldgs %
15.8%
Holding
2,674
New
67
Increased
207
Reduced
1,057
Closed
107

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 14.8%
3 Healthcare 13.78%
4 Industrials 9.72%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
76
ConocoPhillips
COP
$151B
$20.5M 0.25%
329,235
-8,837
-3% -$601K
AMT icon
77
American Tower
AMT
$79B
$19.9M 0.24%
125,969
-2,270
-2% -$355K
USB icon
78
US Bancorp
USB
$100B
$19.9M 0.24%
434,434
-11,039
-2% -$568K
QCOM icon
79
Qualcomm
QCOM
$171B
$19.7M 0.24%
346,656
-62,584
-15% -$3.8M
ELV icon
80
Elevance Health
ELV
$84.7B
$19.4M 0.24%
73,970
-1,653
-2% -$455K
MPLX icon
81
MPLX
MPLX
$60.1B
$19.4M 0.24%
641,043
+119,856
+23% +$4M
UPS icon
82
United Parcel Service
UPS
$88.8B
$19.4M 0.24%
198,812
-2,895
-1% -$314K
CME icon
83
CME Group
CME
$93.2B
$19.2M 0.23%
102,312
+3,233
+3% +$597K
AXP icon
84
American Express
AXP
$230B
$19.1M 0.23%
200,340
-5,062
-2% -$530K
GE icon
85
GE Aerospace
GE
$382B
$18.8M 0.23%
519,026
-8,511
-2% -$384K
LMT icon
86
Lockheed Martin
LMT
$138B
$18.5M 0.23%
70,768
-1,308
-2% -$397K
DHR icon
87
Danaher
DHR
$146B
$18.2M 0.22%
198,972
-3,097
-2% -$281K
DUK icon
88
Duke Energy
DUK
$96.1B
$17.6M 0.21%
203,871
-3,358
-2% -$286K
BIIB icon
89
Biogen
BIIB
$30.1B
$17.3M 0.21%
57,621
-980
-2% -$313K
BDX icon
90
Becton Dickinson
BDX
$49.4B
$17.3M 0.21%
78,631
-1,148
-1% -$266K
CB icon
91
Chubb
CB
$134B
$17M 0.21%
131,779
-2,986
-2% -$386K
MDLZ icon
92
Mondelez International
MDLZ
$78.9B
$16.6M 0.2%
415,734
-10,871
-3% -$463K
GS icon
93
Goldman Sachs
GS
$301B
$16.5M 0.2%
98,936
-3,213
-3% -$648K
ADP icon
94
Automatic Data Processing
ADP
$108B
$16.4M 0.2%
125,187
-2,258
-2% -$319K
TJX icon
95
TJX Companies
TJX
$172B
$15.8M 0.19%
353,910
-10,928
-3% -$552K
WBA
96
DELISTED
Walgreens Boots Alliance
WBA
$15.7M 0.19%
229,915
-15,481
-6% -$1.2M
ISRG icon
97
Intuitive Surgical
ISRG
$142B
$15.6M 0.19%
97,971
-1,296
-1% -$220K
PNC icon
98
PNC Financial Services
PNC
$101B
$15.4M 0.19%
131,963
-3,105
-2% -$396K
SPG icon
99
Simon Property Group
SPG
$71.2B
$14.9M 0.18%
88,452
-1,498
-2% -$268K
MS icon
100
Morgan Stanley
MS
$338B
$14.8M 0.18%
373,738
-11,882
-3% -$519K

Similar funds

MetLife Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, MetLife Investment Management held 2,674 positions worth $8.23B, down 16% from $9.77B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q4 2018 filing shows 67 new, 207 increased, 1,057 reduced and 107 closed positions. Its largest new stake was Equitrans Midstream Corporation Common Stock: 124,047 shares worth $2.48M. The largest sale was Energy Transfer Partners, L.P., an estimated $28.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2018 buy was Equitrans Midstream Corporation Common Stock: 124,047 shares worth $2.48M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $57.5M increase.
  • MetLife Investment Management's biggest Q4 2018 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $12M.
  • MetLife Investment Management fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $28.9M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $8.23B portfolio in Q4 2018.
  • MetLife Investment Management opened 67 new positions and closed 107 in Q4 2018.
  • MetLife Investment Management's portfolio value fell 16% quarter-over-quarter to $8.23B.

Based on MetLife Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.